SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-004862
Filing Date
2013-04-25
Accepted
2013-04-25 16:00:16
Documents
4
Period of Report
2013-06-11
Effectiveness Date
2013-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214633zdef14a.htm DEF 14A 338739
2 G25898.JPG g25898.jpg GRAPHIC 11655
3 G19172BCI001.GIF g19172bci001.gif GRAPHIC 56081
4 G19172BCI002.GIF g19172bci002.gif GRAPHIC 37522
  Complete submission text file 0001047469-13-004862.txt   485445
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35060 | Film No.: 13782821
SIC: 2834 Pharmaceutical Preparations